Clearmind Intangible Assets from 2010 to 2026
| CMND Stock | USD 1.25 0.03 2.46% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 122.8 K | Current Value 126.2 K | Quarterly Volatility 13.8 K |
Check Clearmind Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearmind Medicine's main balance sheet or income statement drivers, such as Interest Expense of 29.9 K, Selling General Administrative of 2.3 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.7. Clearmind financial statements analysis is a perfect complement when working with Clearmind Medicine Valuation or Volatility modules.
Clearmind | Intangible Assets | Build AI portfolio with Clearmind Stock |
Analyzing Clearmind Medicine's Intangible Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Intangible Assets has evolved provides context for assessing Clearmind Medicine's current valuation and future prospects.
Latest Clearmind Medicine's Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of Clearmind Medicine Common over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Clearmind Medicine's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearmind Medicine's overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Clearmind Intangible Assets Regression Statistics
| Arithmetic Mean | 155,034 | |
| Geometric Mean | 154,402 | |
| Coefficient Of Variation | 8.93 | |
| Mean Deviation | 9,864 | |
| Median | 159,800 | |
| Standard Deviation | 13,843 | |
| Sample Variance | 191.6M | |
| Range | 54.6K | |
| R-Value | (0.57) | |
| Mean Square Error | 136.9M | |
| R-Squared | 0.33 | |
| Significance | 0.02 | |
| Slope | (1,576) | |
| Total Sum of Squares | 3.1B |
Clearmind Intangible Assets History
About Clearmind Medicine Financial Statements
Clearmind Medicine stakeholders use historical fundamental indicators, such as Clearmind Medicine's Intangible Assets, to determine how well the company is positioned to perform in the future. Although Clearmind Medicine investors may analyze each financial statement separately, they are all interrelated. For example, changes in Clearmind Medicine's assets and liabilities are reflected in the revenues and expenses on Clearmind Medicine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Clearmind Medicine Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 122.8 K | 126.2 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearmind Medicine Common is a strong investment it is important to analyze Clearmind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearmind Medicine's future performance. For an informed investment choice regarding Clearmind Stock, refer to the following important reports:Check out the analysis of Clearmind Medicine Correlation against competitors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Will Biotechnology sector continue expanding? Could Clearmind diversify its offerings? Factors like these will boost the valuation of Clearmind Medicine. Projected growth potential of Clearmind fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Clearmind Medicine data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Clearmind Medicine Common requires distinguishing between market price and book value, where the latter reflects Clearmind's accounting equity. The concept of intrinsic value - what Clearmind Medicine's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Clearmind Medicine's price substantially above or below its fundamental value.
It's important to distinguish between Clearmind Medicine's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clearmind Medicine should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Clearmind Medicine's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.